StockData
Phibro Animal Health Corp logo

Phibro Animal Health Corp (PAHC) stock

PAHCNasdaqPharmaceutical PreparationsFiscal year ends June 30
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 22/3046% below fair value
$35.57+0.65 (+1.86%)

Close on Nov 18, 2026Market cap $1.44BP/E 14.6Yield 1.35%

Phibro Animal Health pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Phibro Animal Health's pe ratio was 14.5× on Nov 11, 2026, against 25.2× a year earlier. Over the last 5 years it ranged from 10.7× to 385.3×, with a median of 20.4×.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202614.5×−8.0
2025Dec 31, 202522.5×−26.3
2024Dec 31, 202448.8×+26.1
2023Dec 29, 202322.7×+11.0
2022Dec 30, 202211.7×−5.4
2021Dec 31, 202117.0×−1.3
2020Dec 31, 202018.3×−0.1
2019Dec 31, 201918.4×+13.4
2018Dec 31, 20185.0×+0.1
2017Dec 29, 20174.9×−5.7
2016Jul 29, 201610.6×−9.3
2015Dec 31, 201520.0×−11.1
2014Jul 31, 201431.1×–

More Phibro Animal Health figures

See a number that looks wrong?